Latest Breaking News On - Aboutbioxceltherapeutics inc - Page 2 : comparemela.com

BioXcel Therapeutics Announces Update on NIDA-funded Trial of BXCL501 (sublingual dexmedetomidine) for Potential Treatment of Opioid Use Disorder (OUD)

BioXcel Therapeutics Announces Update on NIDA-funded Trial of BXCL501 (sublingual dexmedetomidine) for Potential Treatment of Opioid Use Disorder (OUD)
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

Columbia-university
New-york
United-states
Connecticut
Yale-university
Whitehouse
District-of-columbia
American
Erik-kopp
Brennan-doyle
David-schull
Robert-risinger

BioXcel Therapeutics (BTAI) Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vimal-mehta
Mediarusso-partnersdavid-schull
Bioxcel-therapeuticserik-kopp
Relationsbioxcel-therapeuticsbrennan-doyle
Company-current-report-on-form
Exchange-commission
Trademark-office
Aboutbioxceltherapeutics-inc
While-the-company
Drug-administration
Securities-exchange
Nasdaq